ScreenerHero

SCPS Scopus BioPharma Inc.

NAS · US · Healthcare · Biotechnology · scopusbiopharma.com
0.0006USD0.00%Mkt Cap: 25250 $P/E: —

Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases with unmet medical needs. It offers Duet Platform, which consists of signa…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap25.25K USD
Enterprise Value-1.40M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.61M USD
Revenue/Share—
Last Price0.0006 USD
Fiscal Year EndDec 2022
MR QuarterJun 2023
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA0.15
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.62
EPS (Forward)-1.23
52W Range
0.00015% of range0.0100
52W High0.0100 USD
52W Low0.0001 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE176.86%
ROA-2959.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.13M USD
CapEx (TTM)1.55K USD
FCF Margin—
FCF Yield1942.21%
Net Debt-362.10K USD
Net Debt/EBITDA0.04
Balance Sheet
Debt/Equity—
Current Ratio0.04
Quick Ratio0.03
Book Value/Sh-0.24 USD
Cash/Share0.0090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.08M
Float34.22M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Float0.65%
Short % Out.0.29%
Shares Short60.41K
Short (prev mo.)23.77K
Technical
SMA 500.0004 (+40.8%)
SMA 2000.0004 (+34.5%)
Beta30.04
S&P 52W Chg16.45%
Avg Vol (30d)2.38K
Avg Vol (10d)3.53K
Technical Indicators
RSI (14)72.3
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0006 USD
BB Middle0.0004 USD
BB Lower0.0002 USD
BB Width105.23%
ATR (14)0.0000 USD
Vol Ratio (20d)0.00x